Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 21, 2020
Patent Application Number
15957469
Date Filed
April 19, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure relates to the use of GnRH receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.